Literature DB >> 19705096

[Uro-oncology--update 2009].

T Otto1.   

Abstract

Mesh：

Year:  2009        PMID： 19705096     DOI： 10.1007/s00120-009-2083-4

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  137 in total

1.  Histomorphology of an ileal orthotopic neobladder: 24 Year's follow-up.

Authors:  R Gatti; S Ferretti; G Bucci; M Simonazzi; G Orlandini
Journal:  Acta Anat (Basel)       Date:  1998

2.  Re: Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children. W. H. Cerwinka, H. C. Scherz and A. J. Kirsch. J Urol 2007; 178: 1469-1473.

Authors:  Jonathan C Routh; Brant A Inman; Yuri Reinberg
Journal:  J Urol       Date:  2008-03       Impact factor: 7.450

Review 3.  Current development of mTOR inhibitors as anticancer agents.

Authors:  Sandrine Faivre; Guido Kroemer; Eric Raymond
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

4.  Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.

Authors:  Brian L Cohen; Rolando Rivera; Paholo Barboglio; Angelo Gousse
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

5.  Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium.

Authors:  Thorsten H Ecke; Peter Bartel; Stefan Koch; Jürgen Ruttloff; Franz Theissig
Journal:  Oncol Rep       Date:  2006-12       Impact factor: 3.906

6.  T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism.

Authors:  William O Brant; Maurice M Garcia; Anthony J Bella; Tom Chi; Tom F Lue
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

Review 7.  Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis.

Authors:  Sadeka Shahani; Milena Braga-Basaria; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

8.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

9.  Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Authors:  Anna Bill-Axelson; Lars Holmberg; Frej Filén; Mirja Ruutu; Hans Garmo; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

10.  Targeted therapies in the management of renal cell carcinoma: role of bevacizumab.

Authors:  Bernard Escudier; Jan Cosaert; Sangeeta Jethwa
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.